Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-02-19

Clinical Trial Update: Testing the Addition of Targeted Radiation Therapy to Surgery and the Usual Chemotherapy Treatment (Pemetrexed and Cisplatin [or Carboplatin]) for Stage I-IIIA Malignant Pleural Mesothelioma [Phase 3]

View source ↗

Summary

A Phase 3 trial testing the addition of targeted radiation therapy to surgery and standard pemetrexed plus cisplatin or carboplatin chemotherapy for stage I–III…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alimta (pemetrexed)
  • CARBOPLATIN (Carboplatin)
  • Platinol (cisplatin)

Snippet

Sponsor: NRG Oncology | Conditions: Pleural Biphasic Mesothelioma, Pleural Epithelioid Mesothelioma | Phase 3 | Status: TERMINATED | Results posted: 2025-02-19